Cargando…

Design and Analysis of Effects of Triplet Repeat Oligonucleotides in Cell Models for Myotonic Dystrophy

Myotonic dystrophy type 1 (DM1) is caused by DM protein kinase (DMPK) transcripts containing an expanded (CUG)n repeat. Antisense oligonucleotide (AON)-mediated suppression of these mutant RNAs is considered a promising therapeutic strategy for this severe disorder. Earlier, we identified a 2′-O-met...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-Barriga, Anchel, Mulders, Susan AM, van de Giessen, Jeroen, Hooijer, Jeroen D, Bijl, Suzanne, van Kessel, Ingeborg DG, van Beers, Josee, van Deutekom, Judith CT, Fransen, Jack AM, Wieringa, Bé, Wansink, Derick G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615819/ https://www.ncbi.nlm.nih.gov/pubmed/23511335 http://dx.doi.org/10.1038/mtna.2013.9

Ejemplares similares

Cell Membrane Integrity in Myotonic Dystrophy Type 1: Implications for Therapy
por: González-Barriga, Anchel, et al.
Publicado: (2015)

Intracellular Distribution and Nuclear Activity of Antisense Oligonucleotides After Unassisted Uptake in Myoblasts and Differentiated Myotubes In Vitro
por: González-Barriga, Anchel, et al.
Publicado: (2017)

A low absolute number of expanded transcripts is involved in myotonic dystrophy type 1 manifestation in muscle
por: Gudde, Anke E. E. G., et al.
Publicado: (2016)

Antisense transcription of the myotonic dystrophy locus yields low-abundant RNAs with and without (CAG)n repeat
por: Gudde, Anke E. E. G., et al.
Publicado: (2017)

Somatic CTG•CAG repeat instability in a mouse model for myotonic dystrophy type 1 is associated with changes in cell nuclearity and DNA ploidy
por: van den Broek, Walther JAA, et al.
Publicado: (2007)

Recovery in the Myogenic Program of Congenital Myotonic Dystrophy Myoblasts after Excision of the Expanded (CTG)n Repeat
por: André, Laurène M., et al.
Publicado: (2019)

CRISPR/Cas9-Induced (CTG⋅CAG)(n) Repeat Instability in the Myotonic Dystrophy Type 1 Locus: Implications for Therapeutic Genome Editing
por: van Agtmaal, Ellen L., et al.
Publicado: (2017)

Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy
por: André, Laurène M., et al.
Publicado: (2018)

The expanded CAG repeat in the huntingtin gene as target for therapeutic RNA modulation throughout the HD mouse brain
por: Datson, Nicole A., et al.
Publicado: (2017)

A Tail-Anchored Myotonic Dystrophy Protein Kinase Isoform Induces Perinuclear Clustering of Mitochondria, Autophagy, and Apoptosis
por: Oude Ophuis, Ralph J. A., et al.
Publicado: (2009)

Deciphering the Complex Molecular Pathogenesis of Myotonic Dystrophy Type 1 through Omics Studies
por: Espinosa-Espinosa, Jorge, et al.
Publicado: (2022)

Suppression of Mutant Protein Expression in SCA3 and SCA1 Mice Using a CAG Repeat-Targeting Antisense Oligonucleotide
por: Kourkouta, Eleni, et al.
Publicado: (2019)

Expanded CUG repeats in DMPK transcripts adopt diverse hairpin conformations without influencing the structure of the flanking sequences
por: van Cruchten, Remco T.P., et al.
Publicado: (2019)

CRISPR/Cas Applications in Myotonic Dystrophy: Expanding Opportunities
por: Raaijmakers, Renée H.L., et al.
Publicado: (2019)

A comprehensive atlas of fetal splicing patterns in the brain of adult myotonic dystrophy type 1 patients
por: Degener, Max J F, et al.
Publicado: (2022)

Intrinsic Myogenic Potential of Skeletal Muscle-Derived Pericytes from Patients with Myotonic Dystrophy Type 1
por: Ausems, Cornelia Rosanne Maria, et al.
Publicado: (2019)

Block or degrade? Balancing on- and off-target effects of antisense strategies against transcripts with expanded triplet repeats in DM1
por: El Boujnouni, Najoua, et al.
Publicado: (2023)

Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2007)

Detection of large expansions in myotonic dystrophy type 1 using triplet primed PCR
por: Singh, Susmita, et al.
Publicado: (2014)

MBNL‐dependent impaired development within the neuromuscular system in myotonic dystrophy type 1
por: Tahraoui‐Bories, Julie, et al.
Publicado: (2023)

Creatine kinase B deficient neurons exhibit an increased fraction of motile mitochondria
por: Kuiper, Jan WP, et al.
Publicado: (2008)

Imaging for risk stratification of sudden cardiac death
por: van der Bijl, Pieter, et al.
Publicado: (2022)

Triplet Repeat–Derived siRNAs Enhance RNA–Mediated Toxicity in a Drosophila Model for Myotonic Dystrophy
por: Yu, Zhenming, et al.
Publicado: (2011)

Myotonic dystrophy RNA toxicity alters morphology, adhesion and migration of mouse and human astrocytes
por: Dincã, Diana M., et al.
Publicado: (2022)

(CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage
por: André, Laurène M., et al.
Publicado: (2019)

Systemic cell therapy for muscular dystrophies: The ultimate transplantable muscle progenitor cell and current challenges for clinical efficacy
por: Ausems, C. Rosanne M., et al.
Publicado: (2020)

(18)F-FDG PET/CT for the diagnosis of aortic inflammation in COVID-19
por: van der Bijl, Pieter, et al.
Publicado: (2022)

Shear wave elastography to evaluate hepatic damage in heart failure
por: van der Bijl, Pieter, et al.
Publicado: (2021)

Strongly interacting particles and the triplet hypothesis
por: Van Hove, Léon Charles Prudent
Publicado: (1966)

Author Correction: Myotonic dystrophy RNA toxicity alters morphology, adhesion and migration of mouse and human astrocytes
por: Dincã, Diana M., et al.
Publicado: (2022)

Using a State-of-the-Art Toolbox to Evaluate Molecular and Functional Readouts of Antisense Oligonucleotide-Induced Exon Skipping in mdx Mice
por: Datson, Nicole A., et al.
Publicado: (2020)

Assisted delivery of antisense therapeutics in animal models of heritable neurodegenerative and neuromuscular disorders: a systematic review and meta-analysis
por: van der Bent, M. Leontien, et al.
Publicado: (2018)

A code for optimising triplet layout
por: Van Riesen-Haupt, Leon, et al.
Publicado: (2017)

Focus on Diagnosis and Prognosis to Guide Timing of Intervention in Valvular Heart Disease
por: Stassen, Jan, et al.
Publicado: (2022)

Two Cases of Endometrial Cancer in Twin Sisters with Myotonic Dystrophy
por: Koh, Ezra Y., et al.
Publicado: (2016)

Clinical Outcome Evaluations and CBT Response Prediction in Myotonic Dystrophy
por: van As, Daniël, et al.
Publicado: (2021)

Human brain pathology in myotonic dystrophy type 1: A systematic review
por: Weijs, Ralf, et al.
Publicado: (2021)

Targeting Several CAG Expansion Diseases by a Single Antisense Oligonucleotide
por: Evers, Melvin M., et al.
Publicado: (2011)

Assessment of the feasibility of exon 45–55 multiexon skipping for duchenne muscular dystrophy
por: van Vliet, Laura, et al.
Publicado: (2008)

Structural white matter networks in myotonic dystrophy type 1
por: van Dorst, Maud, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7atma7kh20vlv82cgiqc9ba35a